Trial
NCT03051516
HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions
Phase IVTERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Fred Hutchinson Cancer Center
Collaborators
National Cancer Institute (NCI)
Condition
High Grade Anal Canal Intraepithelial Neoplasia
Intervention
Laboratory Biomarker Analysis
Why stopped
The study was terminated early due to futility.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-02-28